PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
13-Dec-2024 AI in Pharma and Biotech Market Projected Growth at 18.8% CAGR to Reach USD 13.1 billion by 2034 Transparency Market Research
13-Dec-2024 Relief Therapeutics Announces Filing of Form 15F to Terminate SEC Reporting Obligations AccessWire
13-Dec-2024 Join Industry Leaders at the Evolution Summit 2025: Shaping the Future of Clinical Trials Marcus Evans
13-Dec-2024 Marcus Evans Announces the Evolution Summit 2025: A Premier Gathering for Clinical Trial Leaders Marcus Evans
13-Dec-2024 NHS winter vaccine bookings surge following flu ‘tidal wave’ warning NHS England
13-Dec-2024 Revolutionising Care: North Kent College Unveils High-Tech Assisted Living Suites to NHS Trust North Kent College
13-Dec-2024 Ann-Xiaoyan Li appointed new Group CFO and Managing Director of the Romaco Group Romaco Group
13-Dec-2024 Minimally Invasive Surgical Instruments Market Outlook 2032: Expanding from US$ 15.7 billion with an 14.8% CAGR Transparency Market Research
13-Dec-2024 Gene Synthesis Market Outlook 2033: Expanding from US$ 1.6 billion to US$ 14.2 Billion with an 23.6% CAGR Transparency Market Research
13-Dec-2024 Infusion Therapy Market to Experience Strong Growth, Projected to Hit $78.9 million by 2031 | TMR Transparency Market Research
13-Dec-2024 Tyrosine Kinase Inhibitors Market to Experience Strong Growth, Projected to Hit $19.0 Billion by 2026 | TMR Transparency Market Research
13-Dec-2024 Surgical Microscopes Market to Reach USD 1.7 Billion by 2031, Growing at a 8.3 % CAGR | TMR Transparency Market Research
13-Dec-2024 Collagen Market to Reach USD 7.1 Billion by 2028, Growing at a 5.5 % CAGR | TMR Transparency Market Research
13-Dec-2024 Actimed Therapeutics Announces Publication of Successful S-pindolol benzoate (ACM-001.1) Phase 1 Study in The Journal of Cachexia, Sarcopenia and Muscle Actimed Therapeutics
13-Dec-2024 HUTCHMED to Receive Milestone Payment from Takeda following First European Reimbursement for FRUZAQLA® (fruquintinib) HUTCHMED
13-Dec-2024 Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis Sanofi
13-Dec-2024 FAAM-EUROBAT 2024 Concludes with Groundbreaking Advances in Food Allergy and Anaphylaxis Research FAAM-EUROBAT 2024
13-Dec-2024 EVERSANA Earns Prestigious Designations from Leading Organizations for Specialty Pharmacy Operations Excellence, Superior Care for Rare Disease Patients EVERSANA
13-Dec-2024 iTeos Therapeutics Presents Interim A2A-005 Clinical Trial Data, Translational, and Preclinical Data from Inupadenant at ESMO Immuno-Oncology Congress iTeos Therapeutics
13-Dec-2024 Why Minimally Invasive Surgery is the Future of Healthcare Ameco Research